Every date and figure for Symbiotec Pharmalab Limited is sourced directly from NSE board-meeting intimations and the official filings the company submits once results are declared. We don't estimate, guess, or backfill missing data. View the most recent filing ↗
| Period | Revenue | Net profit | EPS | Net margin | Source |
|---|---|---|---|---|---|
| Q1 FY27Latest21 Sep 2026 | ₹211 cr | ₹47 cr | ₹7.49 | 22.3% | Filing ↗ |
Consensus estimates aren't connected to a live production feed yet. This is a feature-availability notice, not a loading error.
Symbiotec Pharmalab Ltd: Board meeting intimation (results)
Source link unavailableSYMBIOTEC PHARMALAB LIMITED: Board meeting intimation (results)
Source link unavailablePress Release
View filing ↗Investor Presentation
View filing ↗This company has no recorded corporate-action filings yet.
This company has no recorded dividend payouts.
Revenue mix isn't wired to a live filings feed in production yet — this isn't a loading error.
No other tracked companies share this sector yet.
This company has no recorded face-value sub-divisions.